Batavia Biosciences BV

Batavia Biosciences BV is an SME in Leiden, Netherlands that has taken part in 6 EU-funded projects since 2012, receiving €2.9M in EU funding.

EU funding received€2.9M
EU projects6
As coordinator0
Running now1
First EU project2012
Latest project2023
CountryNetherlands
EU registration (PIC)972540431
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Batavia Biosciences BV's own share of each project, not the project's full budget.

  • Horizon 2020€1.9M · 2 projects
  • FP7 (2007 to 2013)€518k · 2 projects
  • Horizon Europe€405k · 2 projects

Projects

6 EU-funded projects, newest first. Each links to the official record.

  • iAdsPartner

    Intelligent design of adenovirus vectors (iAds)

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €405ktheir share
  • ReCHISVacAssociated partner

    Experimental vaccinology, revealing unnatural signatures of protection by repeat controlled human schistosome infection.

    Horizon Europe · 2022–2024 · Project on CORDIS ↗

  • CardioReGenixPartner

    CardioReGenix: Development of Next-Generation Gene Therapies for Cardiovascular Disease

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

    €956ktheir share
  • RECOMBPartner

    Stem-cell based gene therapy for recombination deficient SCID (RECOMB)

    Horizon 2020 · 2018–2024 · Project on CORDIS ↗

    €982ktheir share
  • AD-VECPartner

    Adenovirus Vector Technology: Next Generation Systems for Medical Therapy

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €307ktheir share
  • ADVANCEPartner

    ADenoViruses as novel clinical treatments

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €212ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • cardiology
  • cardiovascular diseases
  • gene therapy
  • genomes
  • immunology
  • infectious diseases
  • neurobiology
  • pathology
  • stem cells
  • vaccines

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime